Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from biotechnology

Five SRM professors on Stanford list of ‘World’s Top 2% Scientists’

Five SRM Univ.-AP professors featured in Stanford's 'World's Top 2% Scientists' list for 2023. Congrats to Karthik Rajendran (energy, biotechnology), Rangabhashiyam Selvasembian (earth, environmental sciences), Randhir Kumar, Kshira Sagar Sahoo & Divya Chaturvedi (ICT) for their research achievements. Last year, Univ. faculty also made the list.

The Hindu

3 Biotech Stocks Offering Great Potential for Gains in October

The biotechnology sector has grown exceptionally, primarily driven by innovations that consistently establish the industry as a leading force in vital spheres such as healthcare, agriculture, and environmental equilibrium. Given the industry’s solid prospects, quality biotech stocks BioNTech (BNTX), Puma Biotechnology (PBYI), and Protalix BioTherapeutics (PLX) could be wise portfolio…

StockNews.com

Investors Keeping a Close Eye on These 3 Biotech Stocks

Growing adoption of AI technologies by biopharmaceutical companies and growing foothold of personalized medicine are expected to drive growth in the biotech market. Therefore, it could be wise to buy fundamentally strong biotech stocks Regeneron Pharmaceuticals (REGN), Corcept Therapeutics (CORT), and Incyte (INCY). Read more.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotech Stocks Offering Potential for Gains

Solid foothold of personalized medicine, increasing prevalence of chronic diseases, favorable government initiatives, and rapid digital transformation are opening new avenues for biotech companies. Thus, it could be wise to invest in fundamentally sound biotech stocks BioMarin Pharmaceutical (BMRN), Shionogi (SGIOY), and Exelixis (EXEL)for potential gains. Read on….

StockNews.com

Moderna (MRNA) and 2 More Biotech Stocks That Are Worth Watching

Growing demand for personalized medicines and rising adoption of machine learning tools are expected to boost the biotech industry. Therefore, it could be wise to watch fundamentally strong biotech stocks Moderna (MRNA), Amicus Therapeutics (FOLD), and Entrada Therapeutics (TRDA). Read more.

StockNews.com

Central University of Karnataka opened to offer quality education, not run RSS centre, says RDPR Minister Priyank Kharge

Responding to the clash between two groups of students – Students’ Federation of India (SFI) of the left wing and Akhil Bharatiya Vidyarthi Parishad (ABVP) of the right wing – at the Central University of Karnataka (CUK) near Kalaburagi, Priyank Kharge, Minister for Rural Development & Panchayat Raj and Information…

The Hindu

IIT Guwahati researchers turn tea factory waste to pharma products

The findings of these studies have been published in various international journals including the International Journal of Biological Macromolecules, Chemosphere, and Critical Reviews in Biotechnology.

The Hindu

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Gainers to Consider

Robust demand, technological advancements, government and private investment, are fueling the biotech industry’s expansion and driving game-changing therapies and product development. With the industry anticipated to thrive, fundamentally strong biotech stocks Regeneron Pharmaceuticals (REGN), Biogen (BIIB), and United Therapeutics (UTHR) look poised for substantial gains. Keep reading.

StockNews.com

3 Biotech Stocks to Buy under $20

The growing adoption of advanced technologies by biopharmaceutical companies and the growing demand for personalized medicines are expected to boost the biotech industry. Therefore, it could be wise to buy fundamentally strong biotech stocks MacroGenics (MGNX), Acorda Therapeutics (ACOR), and Shionogi & Co. (SGIOY), which are currently trading under $20.…

StockNews.com

3 Biotech Stocks with Breakout Growth Potential

Fueled by a combination of technological breakthroughs and unparalleled data accessibility, the biotechnology industry is poised for growth in the long term. Hence, fundamentally strong biotech stocks Theratechnologies (THTX), Shionogi (SGIOY), and Gilead Sciences (GILD), which show solid growth potential, might be worth buying. Read on.

StockNews.com

3 Best Biotech Stocks for Health and Wealth

With medical innovations and technological breakthroughs rapidly transforming the healthcare landscape, biotech stocks have garnered unprecedented attention in the investment community. Thus, fundamentally robust stocks like Incyte Corp. (INCY), Vertex Pharmaceuticals (VRTX), and Amgen (AMGN) could contribute to the health and wealth of your portfolios. Read more….

StockNews.com

Top 3 Biotech Stocks to Watch and Buy for Healthy Profits

With innovative approaches and cutting-edge technologies, biotech has ushered in a new era of possibilities in the medical field. Hence, investing in three fundamentally sound biotech stocks, Equillium, Inc. (EQ), Theratechnologies (THTX), and Exelixis (EXEL), could yield healthy profits. Learn more….

StockNews.com

US escalates trade dispute with Mexico over genetically modified corn

Washington requests settlement panel under North American trade deal in push against Mexican curbs on corn imports.

Al Jazeera

3 Biotech Stocks to Buy for August

The biotechnology sector has experienced extraordinary expansion, largely due to technological advancements that continue to position the industry as a pioneering influencer in crucial areas of healthcare, agriculture, and environmental stability. Given this backdrop, quality biotech stocks Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), and United Therapeutics (UTHR) could be solid…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

The Hindu

Henrietta Lacks’ family settles lawsuit with a biotech company that used her cells without consent

Family of Henrietta Lacks settles lawsuit with biotechnology company over her cells, which were taken without her knowledge and used to develop medical innovations. After 70 years, Lacks' descendants reach settlement with Thermo Fisher Scientific Inc. over unjust enrichment from her cells.

The Independent UK

Thermo Fisher Scientific settles with family of Henrietta Lacks, whose HeLa cells uphold medicine

The family of Henrietta Lacks is settling a lawsuit against a biotechnology company it accuses of improperly profiting from her cells

Investors Business Daily

Biogen Stock Tumbles On Plans To Cut 11% Of Workforce; Tops Second-Quarter Estimates

Biogen stock dropped Tuesday after the biotechnology firm said it's eliminating 1,000 jobs as part of a strategy to cut operating expenses.

StockNews.com

3 Top Biotech Stocks to Purchase Right Away

The ever-rising demand for quality healthcare is expected to benefit the biotech industry. Moreover, favorable government initiatives to boost domestic biotech research and production should boost the industry’s prospects. Therefore, it could be wise to buy fundamentally strong biotech stocks Shionogi & Co. (SGIOY), Amicus Therapeutics (FOLD), and Entrada Therapeutics…

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Alan Bull obituary

Other lives: Renowned microbiologist who chaired an OECD working party on biotechnology and industrial sustainability

StockNews.com

3 Biotech Stocks to Acquire in July

With the surge in new drug formulations, the growing prominence of personalized medicine, and favorable government initiatives, the biotech industry is set for significant growth this year and beyond. Thus, it could be wise to invest in fundamentally sound biotech stocks Biogen (BIIB), Alkermes (ALKS), and Theratechnologies (THTX) this month.…

The Hindu

GITAM hosts session on funding opportunities

“The proposition of a project proposal is very important. The intention may be very good, but how are you positioning it? You should be articulate to defend your proposal in terms of positioning, thinking process,“ said Mohammad Aslam, consultant (DBT-ILS) and former adviser, Department of Biotechnology (DBT), Ministry of Science…

Marie Claire

In The Loop: Why the beauty industry is moving towards lab-grown beauty and away from plant-based sourcing

Could biotechnology and the replication of botanicals be vital to the evolution of natural beauty?

The Hindu

Health activists and patient groups seek revision of existing Biosimilar Guideline for increased access to critical drugs

These groups have written to the Central Health Ministry and Department of Biotechnology in this regard

The Hindu

Explained | The problem with India’s new guidelines on genetically modified insects

In April 2023, the Department of Biotechnology (DBT) issued the ‘Guidelines for Genetically Engineered (GE) Insects’. They provide procedural roadmaps for those interested in creating GE insects. They have three problems for researchers, discussed in the article.

StockNews.com

3 Biotech Stocks With 'A' POWR Ratings

The biotech industry is poised for significant growth due to the rising orphan drug formulations and the adoption of emerging technologies. Therefore, fundamentally strong biotech stocks Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and United Therapeutics (UTHR) might be solid buys. These stocks are A (Strong Buy) rated in our proprietary…

1 … 4 5 6 7

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bharatiya Janata Party

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.